{
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "---\n",
        "title: \"Multiple Sclerosis\"\n",
        "subtitle: \"A progressive autoimmune disease of the CNS\"\n",
        "---\n",
        "\n",
        "\n",
        ":::{.callout title=\"Resources\"}\n",
        "\n",
        "- Suzanne - Ch14 @martinNeurologicInterventionsPhysical2021a \n",
        "- Ch16 MS @fulkOSullivanSchmitzsPhysical2024\n",
        "- ch31 MS @goodmanGoodmanFullerPathology2020\n",
        "- Sleep\n",
        "    - Ch109 Autoimmune disorders (MS) @kryger2021SleepMedicine\n",
        "\n",
        ":::\n",
        "\n",
        "\n",
        ":::{.callout-note title=\"AKA\"}\n",
        "\n",
        "- Charcot’s triad @osullivanPhysicalRehabilitation2019 \n",
        ":::\n",
        "\n",
        "Multiple sclerosis (MS) refers to a progressive autoimmune disease where the immune system attacks oligodendrocytes resulting in demyelination of the brain, spinal cord, [CNI Olfactory n.]({{< var ref-cn1.path >}}), and [CNII Optic n.]({{< var ref-cn2.path >}}) @osullivanPhysicalRehabilitation2019.\n",
        "MS is characterized by inflammation, selective demyelination, and gliosis @osullivanPhysicalRehabilitation2019. \n",
        "\n",
        "\n",
        "\n",
        "# Etiology\n",
        "\n",
        ":::{layout-ncol=\"3\"}\n",
        "### Genetics\n",
        "It appears that although individuals do not inherit the disease, they may inherit a genetic susceptibility to immune system dysfunction\n",
        "\n",
        "\n",
        ":::\n",
        "\n",
        "# Pathogenesis\n",
        "\n",
        "Molecular mimicry\n",
        "\n",
        "- An autoimmune response when individuals with a genetic susceptibility are exposed to a viral agent @osullivanPhysicalRehabilitation2019\n",
        "\n",
        "\n",
        "Major Pathologic Mechanisms that result in clinical manifestations @olekManifestationsMultipleSclerosis2023 \n",
        "\n",
        "- Inflammation @olekManifestationsMultipleSclerosis2023 \n",
        "- Demyelination @olekManifestationsMultipleSclerosis2023 \n",
        "- Axonal degeneration @olekManifestationsMultipleSclerosis2023 \n",
        "\n",
        "## Theories\n",
        "\n",
        "Theories(Olek and Mowry 2023)\n",
        "\n",
        "- \"The most widely accepted theory is that MS begins as an inflammatory immune-mediated disorder characterized by autoreactive lymphocytes\" @olekManifestationsMultipleSclerosis2023 \n",
        "- \"Later, the disease is dominated by microglial activation and chronic neurodegeneration\" @olekManifestationsMultipleSclerosis2023\n",
        "\n",
        "# Types of MS {#types}\n",
        "\n",
        "- [Relapsing remitting (RRMS)](#relapsing-remitting)\n",
        "- [Primary progressive (PPMS)](#primary-progressive)\n",
        "- [Secondary progressive (SPMS)](#secondary-progressive)\n",
        "- [Progressive relapsing (PRMS)](#progressive-relapsing)\n"
      ],
      "id": "64f4909f"
    },
    {
      "cell_type": "code",
      "metadata": {
        "message": false
      },
      "source": [
        "#| echo: false\n",
        "#| warning: false\n",
        "\n",
        "\n",
        "import plotly.graph_objects as go\n",
        "\n",
        "# Data for RRMS\n",
        "time_rrms = [0, 1, 1, 2, 2, 3, 3, 4, 4, 5, 5, 6]\n",
        "rrms = [0, 0, 2, 2, 1, 1, 4, 4, 3, 3, 6, 6]\n",
        "\n",
        "# Data for PPMS\n",
        "time_ppms = [0, 6]\n",
        "ppms = [0, 6]\n",
        "\n",
        "# Data for SPMS\n",
        "time_spms = [0, 1, 1, 2, 2, 3, 3, 4, 4, 5, 6]\n",
        "spms = [0, 0, 2, 2, 1, 1, 4, 4, 3, 3.5, 4]\n",
        "\n",
        "# Data for PRMS\n",
        "time_prms = [0, 1, 1, 2, 2, 3, 3, 4, 4, 5, 5, 6]\n",
        "prms = [0, 0, 2, 2, 1, 1.5, 4.5, 4.5, 3, 3.5, 6.5, 6.5]\n",
        "\n",
        "# Create the figure\n",
        "fig = go.Figure()\n",
        "\n",
        "# Add SPMS plot with wider line\n",
        "fig.add_trace(go.Scatter(x=time_spms, y=spms, mode='lines', name='Secondary progressive',\n",
        "                         line=dict(color='orange', width=12), visible='legendonly'))\n",
        "\n",
        "# Add RRMS plot with medium line width\n",
        "fig.add_trace(go.Scatter(x=time_rrms, y=rrms, mode='lines', name='Relapsing remitting',\n",
        "                         line=dict(color='green', width=8), visible='legendonly'))\n",
        "\n",
        "# Add PPMS plot with thin line\n",
        "fig.add_trace(go.Scatter(x=time_ppms, y=ppms, mode='lines', name='Primary progressive',\n",
        "                         line=dict(color='purple', width=8), visible='legendonly'))\n",
        "\n",
        "# Add PRMS plot with another width\n",
        "fig.add_trace(go.Scatter(x=time_prms, y=prms, mode='lines', name='Progressive relapsing',\n",
        "                         line=dict(color='skyblue', width=4), visible=True))\n",
        "\n",
        "# Customize the layout to remove gridlines, ticks, and axis numbers\n",
        "fig.update_layout(\n",
        "    xaxis_title=\"Time\",\n",
        "    yaxis_title=\"Severity\",\n",
        "    legend=dict(x=0.05, y=0.95, bgcolor='rgba(0,0,0,0)', bordercolor='rgba(0,0,0,0)'),\n",
        "    template='plotly_white',\n",
        "    # width=800,\n",
        "    # height=600,\n",
        "    xaxis=dict(showgrid=False, zeroline=False, showline=False, ticks='', showticklabels=False),\n",
        "    yaxis=dict(showgrid=False, zeroline=False, showline=False, ticks='', showticklabels=False),\n",
        "    dragmode=False\n",
        ")\n",
        "\n",
        "# Function to update trace visibility\n",
        "def update_trace_visibility(visible_indices):\n",
        "    for i in range(len(fig.data)):\n",
        "        fig.data[i].visible = 'legendonly' if i not in visible_indices else True"
      ],
      "id": "2c3e94f1",
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "metadata": {
        "message": false
      },
      "source": [
        "#| echo: false\n",
        "#| warning: false\n",
        "#| label: fig-ms-types\n",
        "#| fig-cap: MS Types\n",
        "\n",
        "update_trace_visibility([0,1,2,3])  # Only show SPMS and PRMS\n",
        "fig  # Display the modified plot"
      ],
      "id": "fig-ms-types",
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "## Relapsing remitting (RRMS) {#relapsing-remitting}\n",
        "\n",
        "::: {.columns}\n",
        "::: {.column}\n",
        "- Short duration attacks with full or partial recovery\n",
        "- May or may not leave lasting symptoms/deficits\n",
        "- Most common\n",
        ":::\n",
        "::: {.column}\n"
      ],
      "id": "462f0de3"
    },
    {
      "cell_type": "code",
      "metadata": {
        "message": false
      },
      "source": [
        "#| echo: false\n",
        "#| warning: false\n",
        "#| label: fig-rpms-time-severity\n",
        "#| fig-cap: RPMS time-severity pattern\n",
        "\n",
        "# Call the update function to set trace visibility\n",
        "update_trace_visibility([1])  # Only show RRMS\n",
        "\n",
        "# Modify the layout to adjust figure height\n",
        "fig.update_layout(\n",
        "    height=300  # Decrease the height (default is around 600)\n",
        ")\n",
        "\n",
        "fig  # Display the modified plot"
      ],
      "id": "fig-rpms-time-severity",
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        ":::\n",
        ":::\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "## Primary progressive (PPMS) {#primary-progressive}\n",
        "\n",
        "::: {.columns}\n",
        "::: {.column}\n",
        "- Worsens over time\n",
        "- Lack of attacks/exacerbations\n",
        "- Steady increase in disability\n",
        ":::\n",
        "::: {.column}"
      ],
      "id": "94998ac5"
    },
    {
      "cell_type": "code",
      "metadata": {
        "message": false
      },
      "source": [
        "#| echo: false\n",
        "#| warning: false\n",
        "#| label: fig-ppms-time-severity\n",
        "#| fig-cap: PPMS time-severity pattern\n",
        "\n",
        "update_trace_visibility([2])  # Only show SPMS and PRMS\n",
        "fig  # Display the modified plot"
      ],
      "id": "fig-ppms-time-severity",
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        ":::\n",
        ":::\n",
        "\n",
        "\n",
        "## Secondary progressive (SPMS) {#secondary-progressive}\n",
        "\n",
        "::: {.columns}\n",
        "::: {.column}\n",
        "- Combo of primary progressive and relapsing remitting \n",
        "- Initially relapsing remitting then turns to progressing as sx inc without remission periods \n",
        ":::\n",
        "::: {.column}"
      ],
      "id": "aefa0337"
    },
    {
      "cell_type": "code",
      "metadata": {
        "message": false
      },
      "source": [
        "#| echo: false\n",
        "#| warning: false\n",
        "#| label: fig-spms-time-severity\n",
        "#| fig-cap: SPMS Time-severity pattern\n",
        "\n",
        "\n",
        "update_trace_visibility([0])  # Only show SPMS and PRMS\n",
        "fig  # Display the modified plot"
      ],
      "id": "fig-spms-time-severity",
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        ":::\n",
        ":::\n",
        "\n",
        "\n",
        "## Progressive relapsing (PRMS) {#progressive-relapsing}\n",
        "\n",
        "::: {.columns}\n",
        "::: {.column}\n",
        "\n",
        "- Worst type\n",
        "- Steady inc in disability *with* attacks \n",
        "- Eliminated from usage in 2013 (this type)\n",
        " \n",
        ":::\n",
        "::: {.column}"
      ],
      "id": "6a015602"
    },
    {
      "cell_type": "code",
      "metadata": {
        "message": false
      },
      "source": [
        "#| echo: false\n",
        "#| warning: false\n",
        "#| label: fig-prms-time-severity\n",
        "#| fig-cap: PRMS Time-severity pattern with diagonal connections\n",
        "\n",
        "update_trace_visibility([3])  # Only show SPMS and PRMS\n",
        "fig  # Display the modified plot"
      ],
      "id": "fig-prms-time-severity",
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        ":::\n",
        ":::\n",
        "\n",
        "\n",
        "# EDSS Scale\n",
        "\n",
        "| Score | Rating | Criteria |\n",
        "|-|-|-|\n",
        "| 0.0 | Normal neurological exam | All FS Scores were grade 0 |\n",
        "| 1.0 | No disability | Minimal signs in one FS (i.e., grade 1) |\n",
        "| 1.5 | No disability | Minimal signs in more than one FS* (more than 1 FS grade 1) |\n",
        "| 2.0 | Minimal disability in one FS | (one FS grade 2, others 0 or 1) |\n",
        "| 2.5 | Minimal disability in two FS | (two FS grade 2, others 0 or 1) |\n",
        "| 3.0 | Moderate disability in one FS | One FS grade 3, others 0 or 1 </br> Or </br> mild disability in 3-4 FS (three or four FS grade 2, others 0 or 1) though fully ambulatory. \n",
        "|3.5| Fully ambulatory but with moderate disability in one FS | (one grade 3) and one or two FS grade 2; or two FS grade 3 (others 0 or 1) or five grade 2 (others 0 or 1) |\n",
        "| 4.0 | Fully ambulatory without aid, self-sufficient, up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1), or combination of lesser grades exceeding limits of previous steps; able to walk without aid or rest greater than 500 meters. | |\n",
        "| 4.5 | Fully ambulatory without aid, up and about much of the day, able to work a full day, may otherwise have some limitation of full activity or require minimal assistance; characterized by relatively severe disability usually consisting of one FS grade 4 (others or 1) or combinations of lesser grades exceeding limits of previous steps; able to walk without aid or rest greater than 300 meters | |\n",
        "| 5.0 | Ambulatory without aid or rest for about 200 meters; disability severe enough to impair full daily activities (e.g., to work a full day without special provisions); Usual FS equivalents are one grade 5 alone, others 0 or 1; or combinations of lesser grades usually exceeding specifications for step 4. | |\n",
        "| 5.5 | Ambulatory without aid for about 100 meters; disability severe enough to preclude full daily activities; (Usual FS equivalents are one grade 5 alone, others 0 or 1; or combination of lesser grades usually exceeding those for step 4.0). | |\n",
        "| 6.0 | Intermittent or unilateral constant assistance (cane, crutch, brace) required to walk about 100 meters with or without resting; (Usual FS equivalents are combinations with more than two FS grade 3+) | |\n",
        "| 6.5 | Constant bilateral assistance (canes, crutches, braces) required to walk about 20 meters without resting; (Usual FS equivalents are combinations with more than two FS grade 3+). | |\n",
        "| 7.0 | Unable to walk beyond approximately 5 meters even with aid, essentially restricted to wheelchair; wheels self in standard wheelchair and transfers alone; up and about in wheelchair some 12 hours a day; (Usual FS equivalents are combinations with more than one FS grade 4+; very rarely pyramidal grade 5 alone) | |\n",
        "| 7.5 | Unable to take more than a few steps; restricted to wheelchair; may need aid in transfer; wheels self but cannot carry on in standard wheelchair a full day; May require motorized wheelchair; (Usual FS equivalents are combinations with more than one FS grade 4+) | |\n",
        "| 8.0 | Essentially restricted to bed or chair or perambulated in wheelchair, but may be out of bed itself much of the day; retains many self-care functions; generally has effective use of arms; (Usual FS equivalents are combinations, generally grade 4+ in several systems) | |\n",
        "| 8.5 | Essentially restricted to bed much of day; has some effective use of arm(s); retains some self-care functions; (Usual FS equivalents are combinations, generally 4+ in several systems) | |\n",
        "| 9.0 | Helpless bed patient; can communicate and eat; (Usual FS equivalents are combinations, mostly grade 4+) | |\n",
        "| 9.5 | Totally helpless bed patient; unable to communicate effectively or eat/swallow; (Usual FS equivalents are combinations, almost all grade 4+). | |\n",
        "| 10.0 | Death due to MS | |\n",
        "\n",
        "::: {.callout-note}\n",
        "\n",
        "- Excludes cerebral function grade 1.\n",
        "- Note 1: EDSS steps 1.0 to 4.5 refer to patients who are fully ambulatory and the precise step number is defined by the Functional System score(s). EDSS steps 5.0 to 9.5 are defined by the impairment to ambulation and usual equivalents in Functional Systems scores are provided.\n",
        "- Note 2: EDSS should not change by 1.0 step unless there is a change in the same direction of at least one step in at least one FS.\n",
        "\n",
        ":::\n",
        "\n",
        "\n",
        "## Functional systems (FS)\n",
        "\n",
        "| Functional system | Abbr. | Function |\n",
        "|-|-|\n",
        "| Pyramidal | P | Motor function |\n",
        "| Cerebellar | C11 | |\n",
        "| Brainstem | BS | |\n",
        "| Sensory | S | |\n",
        "| Bowel and Bladder | BB | |\n",
        "| Visual | V | |\n",
        "| Cerebral or Mental | Cb | |\n",
        "| Other | O | |\n",
        "\n",
        "## FS Scoring\n",
        "\n",
        "\n",
        "The FS are scored on a scale of 0 (low level of problems) to 5 or 6 (high level of problems) to best reflect the level of disability observed clinically.\n",
        "The “Other” category consists of any other neurologic findings attributed to MS and is dichotomous, with 0 as none and 1 as any present.\n",
        "In contrast, the total EDSS score is determined by two factors: gait and FS scores.\n",
        "\n",
        "EDSS scores below 4.0 are determined by the FS scores alone.\n",
        "People with EDSS scores of 4.0 and above may have some degree of gait impairment. Scores between 4.0 and 9.5 are determined by both gait abilities and the FS scores.\n",
        "For simplicity, many experts gauge the EDSS scores between 4.0 and 9.5 entirely by gait, without considering the FS scores.\n",
        "The EDSS is widely used and accepted as a valid tool to clinically measure and evaluate MS patients’ level of functioning. \n",
        "\n",
        "\n",
        "\n",
        "# Symptoms {#symptoms}\n",
        "\n",
        "\n",
        ":::{layout-ncol=\"3\"}\n",
        "\n",
        "### Motor\n",
        "- Spasticity\n",
        "    - Spasticity in LE\n",
        "\n",
        "\n",
        "\n",
        "### Coordination\n",
        "\n",
        "- Ataxia\n",
        "- Cerebellar coordination symptoms\n",
        "    - Nystagmus\n",
        "    - Coordination\n",
        "    - Balance\n",
        "    - Ataxia\n",
        "    - Intention tremor\n",
        "\n",
        "### Gait\n",
        "\n",
        "- Scissoring gait\n",
        "- Uneven steps\n",
        "- bladder-spastic/flaccid\n",
        "- Dysphagia\n",
        "- Dysphonia\n",
        "\n",
        "### Cognition\n",
        "\n",
        "- Cognition is diminished attention/concentration, fatigue\n",
        "\n",
        "### Emotion\n",
        "\n",
        "- Pseudobulbar affect - laughing/crying inappropriately \n",
        "\n",
        "### Vision\n",
        "\n",
        "- Optic neuritis\n",
        "- Abnormal Decreased pupillary light reflex (CN2) \n",
        "    - **Marcus gunn pupil**: Light in eye &rarr; pupil will dilate (not restrict) \n",
        "\n",
        "### Sensation\n",
        "\n",
        "- Trigeminal neuralgia present\n",
        "- Numbness/paresthesia\n",
        "\n",
        ":::\n",
        "\n",
        "\n",
        "# Signs\n",
        "\n",
        "- Lhermitte’s Sign\n",
        "    - Neck flexion → electric shock down the spine! Do not do this w/ exercises\n",
        "- Uhthoff’s Phenomenon\n",
        "    - Excessive heat → temporary worsening of symptoms\n",
        "    - Can potentially pre cool them before exercise\n",
        "    - Keep under 85&deg; in water if they go in\n",
        "- Charcot’s Triad\n",
        "    - When cerebellum affected: SIN:\n",
        "        - S - Scanning speech\n",
        "        - I - Intention tremor\n",
        "        - N - Nystagmus \n",
        "- CNII Optic n. dysfunction\n",
        "    - Abnormal pupillary light reflex – dilates and does not restrict w light\n",
        "    - Marcus gunn pupil, blindness\n",
        "\n",
        "\n",
        "\n",
        "# Clinical Presentation\n",
        "\n",
        ":::{layout-ncol=\"3\"}\n",
        "\n",
        "### Onset\n",
        "\n",
        "- 3% to 5% Occur before 16years @osullivanPhysicalRehabilitation2019\n",
        "- Onset of MS typically occurs between ages 20 and 50 years and is uncommon in children @osullivanPhysicalRehabilitation2019 \n",
        "- 9% of patients experience sx onset after 50 yeras old @osullivanPhysicalRehabilitation2019 \n",
        "\n",
        "### Gender\n",
        "\n",
        "- Prevalence: MS occurs more often in women than men (2-3:1) when sx onset before 50y/o  @osullivanPhysicalRehabilitation2019 \n",
        "- Severity: Men experience more progressive disease course and more rapid disability @osullivanPhysicalRehabilitation2019\n",
        "\n",
        ":::\n",
        "\n",
        "\n",
        "\n",
        "\n",
        "# Motor Control\n",
        "\n",
        "- Facilitation\n",
        "    - Bilateral impairments, more stability\n",
        "\n",
        "# Interventions\n",
        "\n",
        "# Fitness prescription\n",
        "\n",
        "Exercise guidelines for MS consistently recommendedL\n",
        "\n",
        "::: {.columns}\n",
        "::: {.column}\n",
        "### Aerobic training\n",
        "\n",
        "- 2 to 3 days/week\n",
        "- 10-30 minutes/session at moderate-intensity\n",
        ":::\n",
        "::: {.column}\n",
        "### Resistance training\n",
        "\n",
        "- 2-3 days/week\n",
        "- 1-3 sets of 8-15 repetitions\n",
        "\n",
        ":::\n",
        ":::\n",
        "\n",
        "\n",
        "\n",
        "Start w 2 days a week of each then progress to 3\n",
        "\n",
        "The intensity should be moderate and range \n",
        "between 11 and 13 on the 20-point rating of perceived exertion scale, or between 40% and 60% peak oxygen consumption or peak heart rate. "
      ],
      "id": "557f51e1"
    }
  ],
  "metadata": {
    "kernelspec": {
      "name": "python3",
      "language": "python",
      "display_name": "Python 3 (ipykernel)",
      "path": "/Users/nathanielyomogida/miniconda3/share/jupyter/kernels/python3"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 5
}